An interventional study of early time restricted eating in Time Restricted Eating, sponsored by University of Mississippi, Oxford. Completed at 1 site in United States. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-23.
Sponsored by University of Mississippi, Oxford · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 113 studies in Intermittent Fasting with a site in United States — 33 open to participants now, 44 under way, none of them phase 3. Intermittent Fasting · United States.
Among the 113 studies in Intermittent Fasting with a site in United States, this one is the 54th largest by enrollment of the 112 interventional ones that give a count, is one of 16 that started in 2023, is one of 104 with no phase, and was the 67th registered.
334 studies on the registry are indexed under Intermittent Fasting; 100 are open to participants now.
Browse Intermittent Fasting studies →33 of the 113 studies in Intermittent Fasting with a site in United States are open now. Recruiting first, the newest first:
University of Maryland, Baltimore · Sites in United States
Ages 55+
Massachusetts General Hospital · Sites in United States
Ages 18–65
Fred Hutchinson Cancer Center · Sites in United States
Ages 18+
Fred Hutchinson Cancer Center · Sites in United States
Ages 21+
University of California, San Diego · Sites in United States
Ages 18–75
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 74 Intermittent Fasting studies recruiting now, 19 (26%) set no upper age limit and 49 (66%) stop at 75 or younger; 4 take children under 18; 22 take healthy volunteers.
This study: 18 Years to 50 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
113 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 5
First in 2010; this study’s year is marked. 16 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 40 is below the median of 50 across 321 interventional studies indexed under Intermittent Fasting.
Median enrollment 40 across the 112 interventional studies, 100 across the 1 observational. Of the 64 that completed or were terminated, 14 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 113 have an industry lead sponsor. The 10 most frequent:
University of Mississippi, Oxford is the lead sponsor of 12 studies on the registry; none are open to participants now.
University of Mississippi, Oxford has 2 studies filed under Intermittent Fasting — fewer than ten, so there is no comparison to draw.
17 of the studies in Intermittent Fasting with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06386887Case Comprehensive Cancer CenterFasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer | 2026-11 |
| NCT07520786University of GeorgiaChanges in 24-hour Activity Cycle Behaviors During a Time-Restricted Eating Intervention in College-Aged Women | 2026-11 |
| NCT07450118University of DelawareNested Pilot Study Comparing Two Treatments to Reduce Type 2 Diabetes Risk in At-Risk Delawareans | 2026-12 |
| NCT05015504OhioHealthApplication of Time Restriction Feeding in Patients With Type 2 Diabetes Mellitus | 2026-12 |
| NCT05943626University of UtahCircadian Intervention to Improve Cardiometabolic Health | 2026-12 |
Add all 17 to your calendar (.ics) → With an account.
Among the 113 studies in Intermittent Fasting with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A randomized controlled trial to determine the effectiveness of early time-restricted eating on muscle performance and body composition in active, resistance trained adults. Two parallel groups will be randomly assigned to either the early time-restricted eating or a control group. All participants will be asked to maintain their usual exercise routines during the 6 week intervention period. Muscle strength and endurance are the primary outcomes. Body composition (body weight, fat mass, fat-free mass and percent body fat), hunger and satiety ratings, sleep quality, energy intake, diet quality, macronutrient composition and adherence are secondary outcome measures.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The Early Time Restricted Eating (eTRE) group will be asked to consume calorie containing food or drinks only between 9am to 5pm, daily. At other times they are to avoid consuming any calorie containing food or drinks.
Behavioral: early time restricted eating
The Control group will follow their usual eating routine.
The intervention group will eat in a prescribed daily feeding window (9am-5pm) and follow their normal exercise and resistance training routines. We will allow up till +/-1 hour for the eating window start and end times while aiming for an 8 hour eating window.
Muscular strength
Pre and post intervention testing of muscular strength using one-rep max
Time frame: 6-weeks
Muscular endurance
Pre and post intervention testing of muscular endurance using barbell bench press and squat.
Time frame: 6-weeks
Body weight (kg)
Pre and post intervention measures of body weight.
Time frame: 6-weeks
Hunger and satiety
Pre and post intervention subjective measure of hunger and satiety with the use of a Hunger and Satiety Visual Analog Scale (minimum value zero, maximum value 10). Higher the score, the more hungry/ less satiated one is.
Time frame: 6-weeks
Sleep quality
Pre and post intervention measure of subjective sleep quality by use of Pittsburgh Sleep Quality Scale. (each question can be scored from 0-3, then an aggregate score of the whole survey can range from 0-21; The higher the score the worst the sleep quality).
Time frame: 6-weeks
Total calorie intake
Pre and post intervention measurements of calorie intake based on 24-hour food recall survey using the Automated Self-Administered 24-hour (ASA24) software.
Time frame: 6-weeks
Diet Quality
Pre and post intervention measurements of diet quality based on 24-hour food recall survey using the ASA24 software and Healthy Eating Index.
Time frame: 6-weeks
Diet macronutrient composition
Pre and post intervention measurements of macronutrients based on 24-hour food recall survey using the ASA24 software.
Time frame: 6-weeks
Adherence
Percent of days during the 6-week trial when eTRE was adhered to as recommended. This will be recorded by the participants daily throughout the entire study.
Time frame: 6-weeks
Fat mass
Pre and post intervention measurements of body fat mass (kg).
Time frame: 6-weeks
Fat-free mass
pre and post intervention measurements of body fat-free mass (kg).
Time frame: 6-weeks
Body fat percentage
Pre and post intervention measurements of body fat percentage.
Time frame: 6-weeks
Plan to share: Yes — We will share the de-identified participant data used in the published manuscript/s by depositing these data in the Open Science Framework (OSF) repository. The data shared will include the sociodemographic data and the outcomes published in the manuscripts. The protocol and statistical analysis plan will be shared as supplementary material through the journal where the study if published, if allowed.
Supporting information: Study protocol, Statistical analysis plan
Time frame: We agree to deposit outcome data into the OSF repository as soon as possible but no later than within two years after the last publication.
No publications or documents are linked to this record.
Ran from Feb 2023 to primary completion in Jun 2023, 3 months.
Of 259 non-industry interventional studies with no phase under Intermittent Fasting, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 34. This study's 3 months is below that.
Counting every sponsor, half of 265 studies reached it within 17 months; a quarter within 8 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Mississippi, Oxford